Monday, 08 August 2022

Daiichi Sankyo establishes new subsidiaries in Australia, Canada, and Singapore

03 December 2021 | News

Strengthening foundation for global business

image credit- shutterstock

image credit- shutterstock

Japan-based pharma firm Daiichi Sankyo Company has established wholly-owned subsidiaries in Australia (Daiichi Sankyo Australia), Canada (Daiichi Sankyo Pharma Canada), and Singapore (Daiichi Sankyo Singapore).

With the establishment of these three subsidiaries, there are now 27 countries in which the Daiichi Sankyo group of companies is present.

Through these subsidiaries, Daiichi Sankyo will contribute to healthcare in countries where it has a base of operations and further strengthen the foundation for its global business, including its oncology products.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account